title: Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior.
abstract: Firing rates of dopamine (DA) neurons in substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) control DA release in target structures such as striatum and prefrontal cortex. DA neuron firing in the soma and release probability at axon terminals are tightly regulated by cholinergic transmission and nicotinic acetylcholine receptors (nAChRs). To understand the role of α6* nAChRs in DA transmission, we studied several strains of mice expressing differing levels of mutant, hypersensitive (leucine 9' to serine [L9'S]) α6 subunits. α6 L9'S mice harboring six or more copies of the hypersensitive α6 gene exhibited spontaneous home-cage hyperactivity and novelty-induced locomotor activity, whereas mice with an equal number of WT and L9'S α6 genes had locomotor activity resembling that of control mice. α6-dependent, nicotine-stimulated locomotor activation was also more robust in high-copy α6 L9'S mice versus low-copy mice. In wheel-running experiments, results were also bi-modal; high-copy α6 L9'S animals exhibited blunted total wheel rotations during each day of a 9-day experiment, but low-copy α6 L9'S mice ran normally on the wheel. Reduced wheel running in hyperactive strains of α6 L9'S mice was attributable to a reduction in both overall running time and velocity. ACh and nicotine-stimulated DA release from striatal synaptosomes in α6 L9'S mice was well-correlated with behavioral phenotypes, supporting the hypothesis that augmented DA release mediates the altered behavior of α6 L9'S mice. This study highlights the precise control that the nicotinic cholinergic system exerts on DA transmission and provides further insights into the mechanisms and consequences of enhanced DA release.
authors.affiliation: Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.
authors.forename: B N
authors.initials: BN
authors.lastname: Cohen
authors.forename: E D W
authors.initials: ED
authors.lastname: Mackey
authors.forename: S R
authors.initials: SR
authors.lastname: Grady
authors.forename: S
authors.initials: S
authors.lastname: McKinney
authors.forename: N E
authors.initials: NE
authors.lastname: Patzlaff
authors.forename: C R
authors.initials: CR
authors.lastname: Wageman
authors.forename: J M
authors.initials: JM
authors.lastname: McIntosh
authors.forename: M J
authors.initials: MJ
authors.lastname: Marks
authors.forename: H A
authors.initials: HA
authors.lastname: Lester
authors.forename: R M
authors.initials: RM
authors.lastname: Drenan
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D003342:Corpus Striatum / Q000648:ultrastructure; D004298:Dopamine / Q000378:metabolism*; D005106:Exploratory Behavior / Q000502:physiology; D006948:Hyperkinesis / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D009043:Motor Activity / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D011978:Receptors, Nicotinic / Q000235:genetics / Q000378:metabolism*; D013574:Synaptosomes / Q000378:metabolism; D013997:Time Factors
chemical_list: D011978:Receptors, Nicotinic; D004298:Dopamine
references.citation: Pharmacol Biochem Behav. 1991 Apr;38(4):723-9
references.pmid: 1871189
references.citation: J Neurosci. 2003 Aug 27;23(21):7820-9
references.pmid: 12944511
references.citation: J Neurosci. 2010 Apr 14;30(15):5311-25
references.pmid: 20392953
references.citation: J Pharmacol Exp Ther. 2002 May;301(2):651-60
references.pmid: 11961070
references.citation: Brain Res Rev. 2007 Nov;56(1):27-78
references.pmid: 17574681
references.citation: Neuropharmacology. 2010 Jun;58(7):1054-66
references.pmid: 20114055
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: J Biotechnol. 2006 May 29;123(3):273-80
references.pmid: 16388869
references.citation: Mol Pharmacol. 2005 Jun;67(6):2007-15
references.pmid: 15749993
references.citation: J Neurosci. 2002 Feb 15;22(4):1208-17
references.pmid: 11850448
references.citation: J Pharmacol Exp Ther. 2006 Feb;316(2):481-9
references.pmid: 16210393
references.citation: Trends Neurosci. 2004 Aug;27(8):468-74
references.pmid: 15271494
references.citation: Integr Comp Biol. 2005 Jun;45(3):438-55
references.pmid: 21676789
references.citation: J Neurosci. 2008 Nov 19;28(47):12318-27
references.pmid: 19020025
references.citation: Science. 2009 May 22;324(5930):1080-4
references.pmid: 19389999
references.citation: J Neurosci. 2010 Jul 21;30(29):9877-89
references.pmid: 20660270
references.citation: Mol Pharmacol. 2004 Jun;65(6):1526-35
references.pmid: 15155845
references.citation: Neuron. 2008 Oct 9;60(1):123-36
references.pmid: 18940593
references.citation: Life Sci. 1990;47(5):421-6
references.pmid: 2395411
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12126-31
references.pmid: 10518587
references.citation: J Neurosci. 2011 Feb 16;31(7):2537-48
references.pmid: 21325521
references.citation: Mol Pharmacol. 2007 Jun;71(6):1563-71
references.pmid: 17341654
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2786-91
references.pmid: 11226318
references.citation: J Neurosci. 2003 Dec 3;23(35):11045-53
references.pmid: 14657161
references.citation: Nat Protoc. 2008;3(6):1101-8
references.pmid: 18546601
references.citation: Nature. 1996 Feb 15;379(6566):606-12
references.pmid: 8628395
references.citation: J Neurosci. 2007 Aug 1;27(31):8202-18
references.pmid: 17670967
references.citation: J Comp Neurol. 2002 Mar 12;444(3):260-74
references.pmid: 11840479
references.citation: Mol Pharmacol. 2000 May;57(5):913-25
references.pmid: 10779374
references.citation: Proc Natl Acad Sci U S A. 2011 May 3;108(18):7577-82
references.pmid: 21502501
references.citation: J Neurosci. 2005 Dec 7;25(49):11396-411
references.pmid: 16339034
references.citation: Nature. 1998 Jan 8;391(6663):173-7
references.pmid: 9428762
references.citation: J Neurosci. 1997 Jul 15;17(14):5263-70
references.pmid: 9204910
references.citation: Physiol Genomics. 2007 Nov 14;31(3):422-8
references.pmid: 17712039
references.citation: Nature. 1995 Aug 10;376(6540):514-6
references.pmid: 7637783
references.citation: J Biol Chem. 1996 Mar 29;271(13):7522-8
references.pmid: 8631783
references.citation: Neuroscience. 1991;44(3):607-12
references.pmid: 1754054
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1982-7
references.pmid: 11172062
references.citation: Biotechniques. 2004 Oct;37(4):610-3
references.pmid: 15517974
references.citation: Neuropsychopharmacology. 2010 Feb;35(3):665-73
references.pmid: 19890263